Versant Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001560009 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value: $963M (100.0% shares, 0.0% debt)

Holdings (12)

CRSP CRISPR Therapeutics AG 48.3%

Value $466M Shares 3,040,462 Est. Cost $40.26 Unrealized +193.6%

— Inari Medical, Inc. 20.8%

Value $201M Shares 2,298,217 Est. Cost $87.29 Unrealized —

— Aligos Therapeutics, Inc. 9.5%

Value $91.03M Shares 3,292,339 Est. Cost $27.65 Unrealized —

— Adverum Biotechnologies, Inc. 5.6%

Value $54.24M Shares 5,003,892 Est. Cost $9770.00 Unrealized —

— Flexion Therapeutics, Inc. 4.6%

Value $44.34M Shares 3,842,578 Est. Cost $10.41 Unrealized —

OCUL Ocular Therapeutix, Inc. 3.1%

Value $30.33M Shares 1,465,384 Est. Cost $20.09 Unrealized -26.1%

CRNX Crinetics Pharmaceuticals, Inc. 3.0%

Value $28.65M Shares 2,030,616 Est. Cost $17.05 Unrealized -18.3%

— Akero Therapeutics, Inc. 2.1%

Value $20.07M Shares 777,727 Est. Cost $21200.00 Unrealized —

— Gritstone Oncology, Inc. 1.8%

Value $17.54M Shares 4,450,638 Est. Cost $7767.86 Unrealized —

— Aprea Therapeutics, Inc. 0.7%

Value $7.018M Shares 1,426,328 Est. Cost $38780.00 Unrealized —

— CymaBay Therapeutics, Inc. 0.3%

Value $3.121M Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.1%

Value $489K Shares 101,855 Est. Cost $56000.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	3,040,462	$466M	48.3%	$40.26	+193.6%	Common Shares	H17182108
—	Inari Medical, Inc.	2,298,217	$201M	20.8%	$87.29	—	Common Stock	45332Y109
—	Aligos Therapeutics, Inc.	3,292,339	$91.03M	9.5%	$27.65	—	Common Stock	01626L105
—	Adverum Biotechnologies, Inc.	5,003,892	$54.24M	5.6%	$9770.00	—	Common Stock	00773U108
—	Flexion Therapeutics, Inc.	3,842,578	$44.34M	4.6%	$10.41	—	Common Stock	33938J106
OCUL	Ocular Therapeutix, Inc.	1,465,384	$30.33M	3.1%	$20.09	-26.1%	Common Stock	67576A100
CRNX	Crinetics Pharmaceuticals, Inc.	2,030,616	$28.65M	3.0%	$17.05	-18.3%	Common Stock	22663K107
—	Akero Therapeutics, Inc.	777,727	$20.07M	2.1%	$21200.00	—	Common Stock	00973Y108
—	Gritstone Oncology, Inc.	4,450,638	$17.54M	1.8%	$7767.86	—	Common Stock	39868T105
—	Aprea Therapeutics, Inc.	1,426,328	$7.018M	0.7%	$38780.00	—	Common Stock	03836J102
—	CymaBay Therapeutics, Inc.	543,753	$3.121M	0.3%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$489K	0.1%	$56000.00	—	Common Stock	189464100